Integrated Localized‑Systemic Adjunctive Protocol
Localized Plaque Application
The primary intervention utilizes localized application of ethically sourced umbilical cord mesenchymal stem cells directly to psoriatic plaques. This targeted approach optimizes the lesional microenvironment while the systemic release of signaling molecules provides additional skin health benefits through immunomodulation and reduced inflammation.
Localized‑systemic integration: Cryopreserved cells from screened donors are applied locally to maximize lesional remodeling effects while their paracrine signaling provides systemic support. This approach recognizes that local plaque improvement benefits from systemic health conditions.
Systemic Physical Therapy Support
Physical therapy serves as a systemic support modality that enhances circulatory efficiency, promotes parasympathetic nervous system engagement, and optimizes the biological environment for the localized therapy to function optimally. This systemic support creates conditions conducive to successful plaque remodeling.
Systemic support objectives: Enhanced systemic circulation supports metabolic waste removal and nutrient delivery throughout the body, improved parasympathetic tone creates optimal healing conditions, and overall biological optimization supports localized therapy effectiveness for psoriasis.
Nutritional Systemic Support
Nutritional optimization provides systemic metabolic support, ensuring adequate substrate availability for cellular processes throughout the body. This creates optimal systemic conditions for localized therapy to achieve maximum benefit while supporting overall skin health and biological efficiency.
Systemic metabolic support: Comprehensive nutritional assessment identifies and addresses systemic deficiencies affecting skin repair, ensuring optimal metabolic function to support both localized lesional remodeling and overall skin health optimization.
Systemic Support for Localized Plaque Therapy
This protocol employs a localized application approach supported by systemic therapies. Localized umbilical cord mesenchymal stem cell application to psoriatic plaques provides targeted lesional remodeling, while systemic physical therapy and nutritional support create optimal conditions for therapeutic success and overall skin health enhancement.
The systemic support components serve dual purposes: Physical therapy enhances circulatory efficiency and promotes parasympathetic engagement systemically, creating optimal healing conditions. Nutritional optimization ensures adequate metabolic substrates throughout the body, supporting both localized lesional remodeling and overall biological function.
Integrated perspective: Localized therapy achieves optimal outcomes when supported by systemic health optimization. This approach recognizes that psoriatic plaque improvement reflects and benefits from systemic biological conditions, providing comprehensive benefits through targeted local intervention with supportive systemic therapies.
Clinical Data: Localized‑Systemic Integration for Psoriasis
Clinical evidence supports the integration of localized therapies with systemic support for psoriatic plaque improvement. Below are relevant clinical statistics.
Clinical interpretation: These data support the integrated localized‑systemic approach. Localized therapies achieve better outcomes when supported by systemic health optimization. Physical therapy and nutritional support create optimal biological conditions for localized plaque intervention success while providing independent skin health benefits. This protocol addresses both targeted plaque remodeling and comprehensive skin health enhancement through this integrated approach.
Localized‑Systemic Integration Protocol for Psoriasis
As Medical Director, I have prepared this clinical guide to explain the integration of localized stem cell application with systemic support therapies. This document provides medical information on how systemic physical therapy and nutritional optimization support localized lesional remodeling outcomes while providing comprehensive skin health benefits.
Integration protocol content includes:
- Localized umbilical cord mesenchymal stem cell application methodology for psoriatic plaques
- Systemic physical therapy protocols supporting localized lesional remodeling
- Nutritional optimization for systemic metabolic support in skin repair
- Integration timing and sequence for optimal plaque improvement results
- Clinical expectations for both localized and systemic skin benefits
- Monitoring parameters for integrated therapeutic response in psoriatic skin
The objective is clinically informed patients who understand how systemic support therapies enhance localized psoriasis treatment outcomes while providing independent skin health optimization benefits.
Integration Protocol Guide
28‑page evidence‑based PDF
No email required. Direct download of clinical information.
Important clinical note: This adjunctive approach is not a replacement for conventional psoriasis treatments (e.g., topical therapies, phototherapy, systemic immunosuppressants, biologics). Patients should continue those treatments under the direction of their prescribing physician.
MSC adjunctive therapy for psoriasis is not approved by the U.S. FDA, Mexican COFEPRIS (for this indication), or any other regulatory agency. It is considered an adjunctive, supportive procedure. Costs are discussed only after a consultation.
Professional Clinical Perspective
As medical professionals specializing in regenerative medicine, we approach psoriasis with a commitment to evidence‑based practice and patient‑centered care. Our integral functional approach recognizes that successful outcomes often require addressing multiple contributing factors simultaneously.
We emphasize transparent communication regarding the current scientific understanding of regenerative techniques, the importance of supportive therapies, and the need for realistic expectations. Each treatment plan is individualized based on comprehensive evaluation, patient history, and specific clinical factors.
Our practice maintains a focus on safety, procedural precision, and thorough follow‑up care to monitor progress and adjust supportive therapies as needed throughout the regenerative process.
— Nexus Regenerative Medicine Clinical Team